177 related articles for article (PubMed ID: 12700669)
1. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2.
Krona C; Ejeskär K; Abel F; Kogner P; Bjelke J; Björk E; Sjöberg RM; Martinsson T
Oncogene; 2003 Apr; 22(15):2343-51. PubMed ID: 12700669
[TBL] [Abstract][Full Text] [Related]
2. Identification and characterization of a 500-kb homozygously deleted region at 1p36.2-p36.3 in a neuroblastoma cell line.
Ohira M; Kageyama H; Mihara M; Furuta S; Machida T; Shishikura T; Takayasu H; Islam A; Nakamura Y; Takahashi M; Tomioka N; Sakiyama S; Kaneko Y; Toyoda A; Hattori M; Sakaki Y; Ohki M; Horii A; Soeda E; Inazawa J; Seki N; Kuma H; Nozawa I; Nakagawara A
Oncogene; 2000 Aug; 19(37):4302-7. PubMed ID: 10980605
[TBL] [Abstract][Full Text] [Related]
3. The two human homologues of yeast UFD2 ubiquitination factor, UBE4A and UBE4B, are located in common neuroblastoma deletion regions and are subject to mutations in tumours.
Carén H; Holmstrand A; Sjöberg RM; Martinsson T
Eur J Cancer; 2006 Feb; 42(3):381-7. PubMed ID: 16386891
[TBL] [Abstract][Full Text] [Related]
4. Deletion of chromosome 1p loci and microsatellite instability in neuroblastomas analyzed with short-tandem repeat polymorphisms.
Martinsson T; Sjöberg RM; Hedborg F; Kogner P
Cancer Res; 1995 Dec; 55(23):5681-6. PubMed ID: 7585654
[TBL] [Abstract][Full Text] [Related]
5. A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation.
Carén H; Ejeskär K; Fransson S; Hesson L; Latif F; Sjöberg RM; Krona C; Martinsson T
Mol Cancer; 2005 Mar; 4(1):10. PubMed ID: 15740626
[TBL] [Abstract][Full Text] [Related]
6. Genetic analysis of p73 localized at chromosome 1p36.3 in primary neuroblastomas.
Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
Med Pediatr Oncol; 2001 Jan; 36(1):42-4. PubMed ID: 11464902
[TBL] [Abstract][Full Text] [Related]
7. Genomic structure and mutational analysis of the human KIF1B gene which is homozygously deleted in neuroblastoma at chromosome 1p36.2.
Yang HW; Chen YZ; Takita J; Soeda E; Piao HY; Hayashi Y
Oncogene; 2001 Aug; 20(36):5075-83. PubMed ID: 11526494
[TBL] [Abstract][Full Text] [Related]
8. p73 at chromosome 1p36.3 is lost in advanced stage neuroblastoma but its mutation is infrequent.
Ichimiya S; Nimura Y; Kageyama H; Takada N; Sunahara M; Shishikura T; Nakamura Y; Sakiyama S; Seki N; Ohira M; Kaneko Y; McKeon F; Caput D; Nakagawara A
Oncogene; 1999 Jan; 18(4):1061-6. PubMed ID: 10023682
[TBL] [Abstract][Full Text] [Related]
9. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
10. Delimitation of a critical tumour suppressor region at distal 1p in neuroblastoma tumours.
Martinsson T; Sjöberg RM; Hallstensson K; Nordling M; Hedborg F; Kogner P
Eur J Cancer; 1997 Oct; 33(12):1997-2001. PubMed ID: 9516841
[TBL] [Abstract][Full Text] [Related]
11. Fine mapping of a tumour suppressor candidate gene region in 1p36.2-3, commonly deleted in neuroblastomas and germ cell tumours.
Ejeskär K; Sjöberg RM; Abel F; Kogner P; Ambros PF; Martinsson T
Med Pediatr Oncol; 2001 Jan; 36(1):61-6. PubMed ID: 11464908
[TBL] [Abstract][Full Text] [Related]
12. Homozygous deletion of CDKN2A (p16INK4a/p14ARF) but not within 1p36 or at other tumor suppressor loci in neuroblastoma.
Thompson PM; Maris JM; Hogarty MD; Seeger RC; Reynolds CP; Brodeur GM; White PS
Cancer Res; 2001 Jan; 61(2):679-86. PubMed ID: 11212268
[TBL] [Abstract][Full Text] [Related]
13. Analyses of apoptotic regulators CASP9 and DFFA at 1P36.2, reveal rare allele variants in human neuroblastoma tumours.
Abel F; Sjöberg RM; Ejeskär K; Krona C; Martinsson T
Br J Cancer; 2002 Feb; 86(4):596-604. PubMed ID: 11870543
[TBL] [Abstract][Full Text] [Related]
14. UBE4B levels are correlated with clinical outcomes in neuroblastoma patients and with altered neuroblastoma cell proliferation and sensitivity to epidermal growth factor receptor inhibitors.
Zage PE; Sirisaengtaksin N; Liu Y; Gireud M; Brown BS; Palla S; Richards KN; Hughes DP; Bean AJ
Cancer; 2013 Feb; 119(4):915-23. PubMed ID: 22990745
[TBL] [Abstract][Full Text] [Related]
15. CHD5, a tumor suppressor gene deleted from 1p36.31 in neuroblastomas.
Fujita T; Igarashi J; Okawa ER; Gotoh T; Manne J; Kolla V; Kim J; Zhao H; Pawel BR; London WB; Maris JM; White PS; Brodeur GM
J Natl Cancer Inst; 2008 Jul; 100(13):940-9. PubMed ID: 18577749
[TBL] [Abstract][Full Text] [Related]
16. Expression and mutational analysis of the DCC, DPC4, and MADR2/JV18-1 genes in neuroblastoma.
Kong XT; Choi SH; Inoue A; Xu F; Chen T; Takita J; Yokota J; Bessho F; Yanagisawa M; Hanada R; Yamamoto K; Hayashi Y
Cancer Res; 1997 Sep; 57(17):3772-8. PubMed ID: 9288786
[TBL] [Abstract][Full Text] [Related]
17. Neuroblastoma tumors with favorable and unfavorable outcomes: Significant differences in mRNA expression of genes mapped at 1p36.2.
Fransson S; Martinsson T; Ejeskär K
Genes Chromosomes Cancer; 2007 Jan; 46(1):45-52. PubMed ID: 17044048
[TBL] [Abstract][Full Text] [Related]
18. Biological characteristics of neuroblastoma with partial deletion in the short arm of chromosome 1.
Hiyama E; Hiyama K; Ohtsu K; Yamaoka H; Fukuba I; Matsuura Y; Yokoyama T
Med Pediatr Oncol; 2001 Jan; 36(1):67-74. PubMed ID: 11464909
[TBL] [Abstract][Full Text] [Related]
19. Mutations in the N-terminal domain of DFF45 in a primary germ cell tumor and in neuroblastoma tumors.
Abel F; Sjöberg RM; Krona C; Nilsson S; Martinsson T
Int J Oncol; 2004 Nov; 25(5):1297-302. PubMed ID: 15492818
[TBL] [Abstract][Full Text] [Related]
20. Analysis of genomic imprinting at 1p35-36 in neuroblastoma.
Hogarty MD; Maris JM; White PS; Guo C; Brodeur GM
Med Pediatr Oncol; 2001 Jan; 36(1):52-5. PubMed ID: 11464906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
